Labviva
PrivateLast Round
Series B
Jan 13, 2025
Total Funding Raised
$55M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Labviva operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Series B round in January 2025.
Labviva is a SaaS and artificial intelligence company that operates an AI-powered digital marketplace intended to offer better visibility into life science supply chains.
Sector
Healthcare & Life Sciences
Verticals
Pharma Supply Chain, Supply Chain, Biotech Equipment
Business Model
B2B
Customer Profile
Subscription SaaS, Marketplace Commission
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Labviva Comparables
Compare Labviva with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zageno | 93% | |
| Science Exchange | 85% | |
| Quartzy | 85% |
For institutional investors. Book with your work email.
Labviva Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 13, 2025 | ||||
| Series A | Mar 27, 2023 | ||||
| Series Seed | Jun 2, 2021 | ||||
| Pre Seed | Aug 4, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Labviva Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Biospring Partners | Series B, Series A |
| B Capital Group | Series B, Series A, Series Seed |
| Tech Coast Angels | Pre Seed |
| Senator Investment Group | Series A, Series Seed |
| 53 Stations | Series B |
| Glasswing Ventures | Series B, Series A, Series Seed, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 55% MoM, reaching 13.8K.
- Oct 27, 2025
Launched 'Smart Suppliers of the Future' AI platform.
For institutional investors. Book with your work email.
Labviva Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Labviva's valuation, stock price, and market status.
Is Labviva a public or private company?
Labviva is a private company.
What is the current stock price of Labviva?
Labviva is a private company, so its shares have no public market price. Caplight tracks Labviva's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Labviva worth (valuation)?
Valuation information for Labviva is not publicly available.
Can I buy Labviva stock?
Labviva shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Labviva's last funding round?
Labviva's most recent funding round was Series B on January 13, 2025.
Who are the main investors in Labviva?
Key investors in Labviva include Biospring Partners, Senator Investment Group, 53 Stations, Glasswing Ventures.
Will Labviva IPO soon?
No public IPO plans have been announced for Labviva.
How can I track Labviva secondary market activity?
Caplight tracks bids, offers, and trades in Labviva's shares on secondary markets.